Vimentin is abundantly expressed in several aggressive cancer cell lines, and broadly reported to play a critical role in acquisition of the migratory and invasive tumor cell phenotype during the epithelial-mesenchymal transition [9]. The gene discussed is VIM; the disease is neoplasm.